SGLT2 Inhibitor‐Associated Changes in Urinary Volatile Organic Compounds in Diabetic Kidney Disease: A Comprehensive Study

ABSTRACT:

SUBMITTER: Hara R 

PROVIDER: S-EPMC12916227 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature